Zevin Asset Management LLC Decreases Position in Danaher Corporation $DHR

Zevin Asset Management LLC trimmed its position in Danaher Corporation (NYSE:DHR) by 7.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 55,380 shares of the conglomerate’s stock after selling 4,672 shares during the period. Danaher comprises about 1.6% of Zevin Asset Management LLC’s portfolio, making the stock its 27th largest holding. Zevin Asset Management LLC’s holdings in Danaher were worth $10,980,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. WFA of San Diego LLC purchased a new stake in shares of Danaher during the second quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new stake in Danaher during the 2nd quarter worth $27,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher during the 3rd quarter worth $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher in the third quarter valued at about $28,000. Finally, Tripletail Wealth Management LLC purchased a new position in shares of Danaher in the third quarter worth about $31,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE DHR opened at $209.56 on Monday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. The company has a market cap of $148.02 billion, a price-to-earnings ratio of 41.58, a price-to-earnings-growth ratio of 2.83 and a beta of 0.91. The stock’s 50-day moving average is $226.85 and its two-hundred day moving average is $216.03. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same period in the prior year, the firm earned $2.14 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s payout ratio is 25.40%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on DHR. Morgan Stanley began coverage on shares of Danaher in a research note on Monday, December 1st. They issued an “overweight” rating and a $270.00 target price on the stock. Guggenheim lifted their price objective on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, January 2nd. Wells Fargo & Company upped their target price on Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Argus set a $265.00 target price on Danaher in a research note on Wednesday, January 14th. Finally, Robert W. Baird set a $251.00 target price on Danaher in a research report on Thursday, January 29th. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $253.86.

Insider Activity at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 11.20% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.